A Study of HS-20110 in Participants With Advanced Solid Tumors

NCT06892379 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: HS-20110 (Phase Ia：Dose escalation )
DRUG: HS-20110 (Phase Ib:Dose expansion )

Sponsor

Hansoh BioMedical R&D Company

Collaborators

[object Object]